Skip to main content
TipRanks
Go Ultimate75% OFF
BrainChild Bio logo

BrainChild Bio: Valuation, Funding & Investors

https://www.brainchildbio.com/Therapeutics

BrainChild Bio is a clinical-stage biotechnology company developing CAR-T cell therapies for tumors in the central nervous system. Its kids-first platform prioritizes pediatric brain tumors, including diffuse intrinsic pontine glioma (DIPG), with plans to expand into additional pediatric and adult CNS tumor indications.

Leadership & Board

Key Executives

Founder
michael jensen
Current Number of Employees
59
Current LinkedIn Followers
5,623

Latest Estimated Valuation

Total Amount Raised
$116M
Total Funding Rounds
1
Latest Funding Amount
$116M
Latest Funding Round
Series A

Company Momentum

Positive
Articles Published on TipRanks1
LinkedIn Trend+0.66% followers
Workforce Trend+0.0% employees

BrainChild Bio LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.

Employee Trend

BrainChild Bio had 59 employees as of November 9, 2026. The number of employees increased by 0 (0.00%) week-over-week.

59Latest Employee Count
0(0.00%)Week-Over-Week Change
020406080Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Social Trend

BrainChild Bio had 5,623 followers as of November 9, 2026. The number of followers increased by 37 (0.66%) week-over-week.

5,623Latest Followers Count
37(0.66%)Week-Over-Week Change
02,0004,0006,0008,000Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Sep 09, 2026Series A$116.00M―

Similar Companies

A snapshot of private companies similar to BrainChild Bio, helping you discover and navigate related company profiles.

Related News and Analysis